Common Nausea, Vomiting, Headache, Fever, Lung infection, Decreased white blood cell count (neutrophils), Nose bleed, Anemia, Reduced blood platelets, Diarrhoea, Pneumonia.

Expert advice for Deczuba Injection
You should undergo frequent examinations of complete blood count before every dosing cycle to check development of neutropenia (abnormally low white blood cell count) or thrombocytopenia (abnormally low count of platelets in the blood).You should regularly be monitor and treated accordingly for signs and symptoms of infections or any unusual bleeding as decitabine is known to suppress the activity of the immune system and affects blood clotting functions.Take extreme care to avoid pregnancy while on decitabine therapy. Consult your doctor if you get to know that you are pregnant.

Q. Is Deczuba a vesicant?
Deczuba is not a vesicant and is not known to cause severe local tissue damage upon extravasation (leaking of injected Deczuba into the surrounding tissues from the site of administration) when injected

Q. How effective is Deczuba?
The effectiveness of Deczuba depends upon several factors including the patient's clinical condition, number of treatment cycles etc. and may vary depending upon the individual response

Q. Does Deczuba cause hair loss?
Yes. Hair loss (alopecia) is among the known side effects of Deczuba

Q. How is Deczuba administered?
Deczuba comes as a powder to be to be added to fluid and injected slowly over 3 hours into a vein (slow i.v infusion) by a doctor who is experienced in giving chemotherapy medications for cancer in a hospital or a clinic.